Sensitivity of cancer cells to carboplatin involves increased activity of mTORC1/2 signaling and DNA damage and repair functions, and targeting AKT/mTOR pathway impairs DNA repair responses, resulting in increased chemosensitivity in a variety of cancers [44,45]. This evidence concerns the gene AKT1 and cancer.